Presidio Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Presidio Capital Management's ABBV Position: Q2 2026 in Review
Presidio Capital Management reduced its AbbVie (ABBV) stake by 5.8% in Q2 2026, selling an estimated $12.9K and leaving 970 shares worth $244K. The position accounts for 0.06% of the portfolio, ranked #72.
Presidio Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $571K in Q1 2022. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Presidio Capital Management held 970 shares of AbbVie worth $244K as of Q2 2026.
- Presidio Capital Management sold 60 AbbVie shares in Q2 2026, an estimated $12.9K.
- AbbVie made up 0.06% of Presidio Capital Management's portfolio in Q2 2026, its #72 holding.
- Presidio Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Presidio Capital Management's AbbVie position peaked at $571K in Q1 2022.
- 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Presidio Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.